Fig 2.
(A) Cumulative incidence of non-relapse mortality (NRM), (B) progression-free survival and (C) overall survival in the post-transplant cyclophosphamide (PTCy) group compared with the conventional group, all patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.